Click 
to remove filters
Novartis Pharmaceuticals UK has appointed Lowe Fusion Healthcare (LFH) to raise its profile among customers.
Fuel PR has been appointed to handle PR for Nucare, the healthcare organisation with specialist marketing services to independent pharmacists. Fuel PR director Gillian Waddell will run the account.
Fiona Tigar, head of PR at drugs giant Astra Zeneca, has made four appointments. Edel McCaffrey, Dominic Wake, Rachael Wood and Anna Isaacs have joined as PR managers. Wake and Wood join from Hill and Knowlton, while McCaffrey was at GCI Healthcare. Isaacs was freelance, but has previously worked at...
Karen Moyse, former deputy chief executive of Hill and Knowlton, and managing director of its pharmaceutical practice, has started her own consultancy, Kinetic Public Relations.
Kinetic Public Relations' claim to be the first direct-to-consumer pharmaceutical consultancy will no doubt ruffle a few feathers in the world of healthcare PR. DTC is the current buzzword and there has been a dramatic rise sector-wide in disease awareness work in particular.
Pharmaceuticals wholesaler and retailer, Alliance UniChem, has hired Gerald Gradwell as head of IR. Gradwell joins from corporate and financial consultancy Gavin Anderson and Company, where he was a director working on the Alliance UniChem account. Gradwell is to be replaced by Liz Morley, who joined...
Drug firm Novartis UK is on the hunt for a corporate affairs director following the resignation of Fiona Fong.
Electrobug, launching this week, is aiming to be a consumer guide for home electronic goods, providing information and tools to consumers when they are buying such products. Revenue is expected to be derived mainly from advertising but the site is also planning to roll out tools providing value-added...
Electrobug, launching this week, is aiming to be a consumer guide for home electronic goods, providing information and tools to consumers when they are buying such products. Revenue is expected to be derived mainly from advertising but the site is also planning to roll out tools providing value-added...
MADISON, NJ: Shandwick and pharmaceuticals client Schering-Plough are under investigation by the Food and Drugs Administration (FDA) over allegations they engaged in a deceptive grass roots campaign to sell the hepatitis C drug Rebetron.
© Haymarket Media Group Ltd. | Terms & Conditions | Contact us